Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul:203:72-73.
doi: 10.1016/j.thromres.2021.04.027. Epub 2021 May 3.

Therapeutic anticoagulation in COVID-19 patients

Anna Cristina Bertoldi Lemos  1 , Douglas Alexandre do Espírito Santo  1 , Carlos Henrique Miranda  2
Affiliations

Therapeutic anticoagulation in COVID-19 patients

Anna Cristina Bertoldi Lemos et al. Thromb Res. 2021 Jul.
No abstract available

Keywords: Anticoagulant treatment; COVID-19; Coagulopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Lemos A.C.B., do Espirito Santo D.A., Salvetti M.C., Gilio R.N., Agra L.B., Pazin-Filho A., Miranda C.H. Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial. HESACOVIDThromb. Res. 2020;196:359–366. - PMC - PubMed
    1. Mehran R., Rao S.V., Bhatt D.L., Gibson C.M., Caixeta A., Eikelboom J., Kaul S., Wiviott S.D., Menon V., Nikolsky E., Serebruany V., Valgimigli M., Vranckx P., Taggart D., Sabik J.F., Cutlip D.E., Krucoff M.W., Ohman E.M., Steg P.G., White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736–2747. - PubMed
    1. S. Schulman, C. Kearon, S. Subcommittee on Control of Anticoagulation of the, T. Standardization Committee of the International Society on, Haemostasis, Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients, J Thromb Haemost 3(4) (2005) 692–4. - PubMed
    1. Full-dose blood thinners decreased need for life support and improved outcomes in hospitalized COVID-19 patients. National Institutes of Health (NIH); 2021. https://www.nih.gov/news-events/new-releases/full-dose-blood-thinners-de...
    1. I. Investigators, P. Sadeghipour, A.H. Talasaz, F. Rashidi, B. Sharif-Kashani, M.T. Beigmohammadi, M. Farrokhpour, S.H. Sezavar, P. Payandemehr, A. Dabbagh, K.G. Moghadam, S. Jamalkhani, H. Khalili, M. Yadollahzadeh, T. Riahi, P. Rezaeifar, O. Tahamtan, S. Matin, A. Abedini, S. Lookzadeh, H. Rahmani, E. Zoghi, K. Mohammadi, P. Sadeghipour, H. Abri, S. Tabrizi, S.M. Mousavian, S. Shahmirzaei, H. Bakhshandeh, A. Amin, F. Rafiee, E. Baghizadeh, B. Mohebbi, S.E. Parhizgar, R. Aliannejad, V. Eslami, A. Kashefizadeh, H. Kakavand, S.H. Hosseini, S. Shafaghi, S.F. Ghazi, A. Najafi, D. Jimenez, A. Gupta, M.V. Madhavan, S.S. Sethi, S.A. Parikh, M. Monreal, N. Hadavand, A. Hajighasemi, M. Maleki, S. Sadeghian, G. Piazza, A.J. Kirtane, B.W. Van Tassell, P.P. Dobesh, G.W. Stone, G.Y.H. Lip, H.M. Krumholz, S.Z. Goldhaber, B. Bikdeli, Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION Randomized clinical trial, JAMA (2021). - PMC - PubMed